Fetuin-A levels in hyperthyroidism

Detalhes bibliográficos
Autor(a) principal: Pamuk, Bariş Onder
Data de Publicação: 2013
Outros Autores: Yilmaz, Hamiyet, Topcuoglu, Tugba, Bilgir, Oktay, Çalan, Ozlem, Pamuk, Gulseren, Ertugrul, Derun Taner
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/72137
Resumo: OBJECTIVE: Fetuin-A is a protein secreted from the liver that inhibits arterial calcification deposition and can contribute to insulin resistance. Hyperthyroidism is also associated with insulin resistance. It is not known whether hyperthyroidism has an effect on fetuin-A levels. METHODS: We measured fetuin-A levels and homeostasis model of assessment-insulin resistance before hyperthyroidism treatment was initiated and after euthyroidism was achieved. A total of 42 patients diagnosed with hyperthyroidism were enrolled in this study. Fetuin-A, insulin, high-sensitivity C-reactive protein, fasting blood glucose, free T3 (fT3), free T4 (fT4), and thyrotropin were measured before and after euthyroidism was established. RESULTS: Basal fasting blood glucose, high-sensitivity C-reactive protein, insulin, c-peptide, homeostasis model of assessment-insulin resistance, fT3, fT4 and fetuin-A levels were significantly decreased after euthyroidism was achieved (Table 1). Basal fasting blood glucose (r:0.407, p:0.008), high-sensitivity C-reactive protein (r:0.523, p
id USP-19_7e3ba95ea17817d7908673ff164cc281
oai_identifier_str oai:revistas.usp.br:article/72137
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Fetuin-A levels in hyperthyroidismFetuin-AHyperthyroidismInsulin ResistanceOBJECTIVE: Fetuin-A is a protein secreted from the liver that inhibits arterial calcification deposition and can contribute to insulin resistance. Hyperthyroidism is also associated with insulin resistance. It is not known whether hyperthyroidism has an effect on fetuin-A levels. METHODS: We measured fetuin-A levels and homeostasis model of assessment-insulin resistance before hyperthyroidism treatment was initiated and after euthyroidism was achieved. A total of 42 patients diagnosed with hyperthyroidism were enrolled in this study. Fetuin-A, insulin, high-sensitivity C-reactive protein, fasting blood glucose, free T3 (fT3), free T4 (fT4), and thyrotropin were measured before and after euthyroidism was established. RESULTS: Basal fasting blood glucose, high-sensitivity C-reactive protein, insulin, c-peptide, homeostasis model of assessment-insulin resistance, fT3, fT4 and fetuin-A levels were significantly decreased after euthyroidism was achieved (Table 1). Basal fasting blood glucose (r:0.407, p:0.008), high-sensitivity C-reactive protein (r:0.523, pHospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/7213710.1590/clin.v68i3.72137Clinics; Vol. 68 No. 3 (2013); 379-383Clinics; v. 68 n. 3 (2013); 379-383Clinics; Vol. 68 Núm. 3 (2013); 379-3831980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/72137/75372Pamuk, Bariş OnderYilmaz, HamiyetTopcuoglu, TugbaBilgir, OktayÇalan, OzlemPamuk, GulserenErtugrul, Derun Tanerinfo:eu-repo/semantics/openAccess2014-01-28T17:05:37Zoai:revistas.usp.br:article/72137Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-01-28T17:05:37Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Fetuin-A levels in hyperthyroidism
title Fetuin-A levels in hyperthyroidism
spellingShingle Fetuin-A levels in hyperthyroidism
Pamuk, Bariş Onder
Fetuin-A
Hyperthyroidism
Insulin Resistance
title_short Fetuin-A levels in hyperthyroidism
title_full Fetuin-A levels in hyperthyroidism
title_fullStr Fetuin-A levels in hyperthyroidism
title_full_unstemmed Fetuin-A levels in hyperthyroidism
title_sort Fetuin-A levels in hyperthyroidism
author Pamuk, Bariş Onder
author_facet Pamuk, Bariş Onder
Yilmaz, Hamiyet
Topcuoglu, Tugba
Bilgir, Oktay
Çalan, Ozlem
Pamuk, Gulseren
Ertugrul, Derun Taner
author_role author
author2 Yilmaz, Hamiyet
Topcuoglu, Tugba
Bilgir, Oktay
Çalan, Ozlem
Pamuk, Gulseren
Ertugrul, Derun Taner
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pamuk, Bariş Onder
Yilmaz, Hamiyet
Topcuoglu, Tugba
Bilgir, Oktay
Çalan, Ozlem
Pamuk, Gulseren
Ertugrul, Derun Taner
dc.subject.por.fl_str_mv Fetuin-A
Hyperthyroidism
Insulin Resistance
topic Fetuin-A
Hyperthyroidism
Insulin Resistance
description OBJECTIVE: Fetuin-A is a protein secreted from the liver that inhibits arterial calcification deposition and can contribute to insulin resistance. Hyperthyroidism is also associated with insulin resistance. It is not known whether hyperthyroidism has an effect on fetuin-A levels. METHODS: We measured fetuin-A levels and homeostasis model of assessment-insulin resistance before hyperthyroidism treatment was initiated and after euthyroidism was achieved. A total of 42 patients diagnosed with hyperthyroidism were enrolled in this study. Fetuin-A, insulin, high-sensitivity C-reactive protein, fasting blood glucose, free T3 (fT3), free T4 (fT4), and thyrotropin were measured before and after euthyroidism was established. RESULTS: Basal fasting blood glucose, high-sensitivity C-reactive protein, insulin, c-peptide, homeostasis model of assessment-insulin resistance, fT3, fT4 and fetuin-A levels were significantly decreased after euthyroidism was achieved (Table 1). Basal fasting blood glucose (r:0.407, p:0.008), high-sensitivity C-reactive protein (r:0.523, p
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/72137
10.1590/clin.v68i3.72137
url https://www.revistas.usp.br/clinics/article/view/72137
identifier_str_mv 10.1590/clin.v68i3.72137
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/72137/75372
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 68 No. 3 (2013); 379-383
Clinics; v. 68 n. 3 (2013); 379-383
Clinics; Vol. 68 Núm. 3 (2013); 379-383
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222759809187840